. Sftg--has, Prise en charge du patient adulte se plaignant d'insomnie en médecine générale. Médecine Sommeil, vol.4, pp.5-27, 2007.

N. Buscemi, B. Vandermeer, C. Friesen, L. Bialy, M. Tubman et al., Agency for Healthcare Research and Quality (US), 2005.

H. Masson, Ancien Président de l'Association mondiale de psychiatrie Membre de l'Académie de médecine, p.1082

N. Buscemi, B. Vandermeer, C. Friesen, L. Bialy, M. Tubman et al., Manifestations and Management of Chronic Insomnia in Adults. Agency for Healthcare Research and Quality (US), 2005.

D. Léger, M. Ohayon, F. Beck, and M. Vecchierini, Prévalence de l'insomnie : actualité épidémiologique. Médecine Sommeil, vol.7, pp.139-184, 2010.

D. Leger, C. Guilleminault, J. P. Dreyfus, C. Delahaye, and M. Paillard, Prevalence of insomnia in a survey of 12,778 adults in France, J Sleep Res, vol.9, issue.1, pp.35-42, 2000.

D. Léger and V. Bayon, Societal costs of insomnia, Sleep Med Rev, vol.14, issue.6, pp.379-89, 2010.

D. Léger, F. Allaert, and M. Massuel, La perception de l'insomnie en médecine générale: Enquête auprès de 6 043 médecins généralistes. Presse Médicale, vol.34, pp.1358-62, 2005.

R. R. Bootzin and M. L. Perlis, Nonpharmacologic treatments of insomnia, J Clin Psychiatry, vol.53, pp.37-41, 1992.

A. Rossat, B. Fantino, B. Bongue, A. Colvez, C. Nitenberg et al., Association between benzodiazepines and recurrent falls: a cross-sectional elderly population-based study, J Nutr Health Aging, vol.15, issue.1, pp.72-79, 2011.

K. Donnelly, R. Bracchi, J. Hewitt, P. A. Routledge, and B. Carter, Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis, PloS One, vol.12, issue.4, p.174730, 2017.

H. Verdoux, R. Lagnaoui, and B. Begaud, Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies, Psychol Med, vol.35, issue.3, pp.307-322, 2005.

S. L. Gray, S. Dublin, O. Yu, R. Walker, M. Anderson et al., Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study, BMJ, vol.352, p.90, 2016.

H. Möhler, . Physiology, . Pharmacology, and . System, GABA and Sleep: Molecular, Functional and Clinical Aspects, pp.3-23, 2010.

N. Buscemi, B. Vandermeer, C. Friesen, L. Bialy, M. Tubman et al., The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs, J Gen Intern Med, vol.22, issue.9, pp.1335-50, 2007.

Y. Sun, C. Lin, C. Lu, C. Hsu, and C. Kao, Association Between Zolpidem and Suicide: A Nationwide Population-Based Case-Control Study, Mayo Clin Proc, vol.91, issue.3, pp.308-323, 2016.

, Etat des lieux de la consommation des benzodiazépines -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2018.

M. Rousselet, F. Feuillet, M. Gerardin, P. Jolliet, J. Hardouin et al., The French addictovigilance network clinical assessment: Z-drugs, true false twins, Expert Opin Drug Saf, vol.16, issue.9, pp.1063-1072, 2017.

C. Victorri-vigneau, F. Feuillet, L. Wainstein, M. Grall-bronnec, J. Pivette et al., Pharmacoepidemiological characterisation of zolpidem and zopiclone usage, Eur J Clin Pharmacol, vol.69, issue.11, pp.1965-72, 2013.

H. Bastuji, Mésusage des médicaments du sommeil et de la vigilance: De l'effet indésirable à l'addiction, Ann Pharm Fr, vol.65, issue.4, pp.265-272, 2007.

, Prescription obligatoire du zolpidem sur ordonnance sécurisée -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2018.

B. Combes, Evaluation de l'impact de la réforme des conditions de prescription et délivrance du zolpidem: étude pilote, 2018.

E. Chambost and M. Chappuy, Impact de la nouvelle réglementation du zolpidem -enquête dans la circonscription départementale du Rhône, Pharm Hosp Clin [Internet], 2018.

J. Barraud and P. Jolliet, Nouvelles règles de prescription et de délivrance du flunitrazépam: étude de l'impact sur la consommation en hypnotiques d'une cohorte. France, 2004.

C. Victorri-vigneau, G. Basset, M. Bourin, and P. Jolliet, Impacts de la nouvelle réglementation du flunitrazépam sur la consommation d'hypnotiques. Thérapie, vol.58, pp.425-455, 2003.

F. Schifano, S. Chiappini, J. M. Corkery, and A. Guirguis, An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions, Int J Neuropsychopharmacol, vol.22, issue.4, pp.270-277, 2019.

, Guidance | Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | Guidance | NICE, 2019.

, Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation, 2019.

A. Noormandi, M. Shahrokhi, and H. Khalili, Potential benefits of zolpidem in disorders of consciousness, Expert Rev Clin Pharmacol, vol.10, issue.9, pp.983-92, 2017.

L. Soler, P. Sancho-gómez, C. Calbó-caldentey, and G. Flores-mateo, Effectiveness of Valerian on insomnia: A meta-analysis of randomized placebo-controlled trials, Melatonin for the Treatment of Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines -NCBI Bookshelf, vol.11, pp.505-516, 2010.

E. Stevinson-null and . Null, Valerian for insomnia: a systematic review of randomized clinical trials, Sleep Med, vol.1, issue.2, pp.91-100, 2000.

F. Péhourcq and M. Molimard, Pharmacocinétique chez le sujet âgé, 2008.

H. Everitt, D. S. Baldwin, B. Stuart, G. Lipinska, A. Mayers et al., Antidepressants for insomnia in adults, Cochrane Database Syst Rev, vol.5, p.10753, 2018.

C. Sirdifield, S. Y. Chipchase, S. Owen, and A. N. Siriwardena, A Systematic Review and Meta-Synthesis of Patients' Experiences and Perceptions of Seeking and Using Benzodiazepines and Z-Drugs: Towards Safer Prescribing. The Patient, vol.10, pp.1-15, 2017.

M. Liebrenz, M. Gehring, A. Buadze, and C. Caflisch, High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal. BMC Psychiatry, vol.15, p.116, 2015.

C. Yen, C. Ko, Y. Chang, C. Yu, M. Huang et al., Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam. Asia-Pac Psychiatry Off J Pac Rim Coll Psychiatr, vol.7, pp.298-305, 2015.

C. Yen, Y. , C. Ko, C. Hwang, T. Chen et al., Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users, Subst Use Misuse, vol.50, issue.3, pp.350-357, 2015.

A. Revet, A. Yrondi, and F. Montastruc, Règles de bon usage des benzodiazépines, Presse Médicale, vol.47, issue.10, pp.872-879, 2018.

, Arrêt des benzodiazépines et médicaments apparentés : démarche du médecin traitant en ambulatoire

H. Autorité-de-santé, , 2019.

M. La-démographie,

, Conseil National de l'Ordre des Médecins, 2019.

. Prs-occitanie, , 2019.

H. P. Rodriguez, T. Von-glahn, W. H. Rogers, H. Chang, G. Fanjiang et al., Evaluating patients' experiences with individual physicians: a randomized trial of mail, internet, and interactive voice response telephone administration of surveys, Med Care, vol.44, issue.2, pp.167-74, 2006.

, Faking it: social desirability response bias in self-report research, vol.25, p.10, 2005.